PP 10 - Point-prevalence survey of antibacterial use in selected public hospitals in Sri Lanka: Findings and implications for practiceplications for practice
Wickramasinghe SS1,2, Wijayaratne GB1,2, Bodinayake CK2.3,15, Weerasinghe SA2, Thabrew HHPMJ1,2, Dharmaratne GSK4, Priyarangani WKAP5, Priyanthi AAD6, Devakanthan B7, Francis VR8, Ranasinghe T9, Patabendige G 10, Kothalawala M 10, Abeywardena M11, Abeykoon M11, Ramachandran R12, Suganthan N13, Wickramasuriya U14, Obale A15, Ramanayake SV2, Ubeysekara H16, Kurukulasooriya MRP2, Anderson D17, Woods CW15,17, Tillekeratne LG2,3,15,17, Nagahawatte ADS1,2,15 , 1Department of Microbiology, Faculty of Medicine, University of Ruhuna, Sri Lanka, 2Duke-Ruhuna Collaborative Research Center, Faculty of Medicine, University of Ruhuna, Sri Lanka, 3Department of Medicine, Faculty of Medicine, University of Ruhuna, Sri Lanka, 4Ministry of Health, Sri Lanka, 5District General Hospital, Hambantota, Sri Lanka, 6Base Hospital, Tangalle, Sri Lanka, 7Teaching Hospital, Batticaloa, Sri Lanka, 8Faculty of Healthcare Sciences, Eastern University, Sri Lanka, 9Faculty of Medical Sciences, University of Sri Jayawardenapura, Sri Lanka, 10National Hospital of Sri Lanka, Colombo, Sri Lanka, 11National Hospital Kandy, Kandy, Sri Lanka, 12Teaching Hospital Jaffna, Jaffna, Sri Lanka, 13Faculty of Medicine, University of Jaffna, Sri Lanka, 14Teaching Hospital Anuradhapura, Anuradhapura, Sri Lanka, 15Duke Global health Institute, NC, USA, 16Provincial Director Office, Sabaragamuwa province, Sri Lanka, 17Department of Medicine, Duke University School of Medicine, NC, USA
Abstract
Introduction
Antimicrobial resistance (AMR) is a global health crisis that is driven by inappropriate antibacterial use.
Objectives
The study aimed to identify the prevalence, patterns and indications of antibacterial use in selected public hospitals in Sri Lanka.
Design, setting, and methods
Single-day, point-prevalence surveys according to standard WHO protocol were conducted among inpatients in medical, surgical, and pediatric wards and intensive-care units (ICU) in 18 public hospitals in six provinces in Sri Lanka in Aug-Nov 2024. One each from tertiary, secondary and primary-level hospitals were included per province. Type of antibacterial prescribed, indications, and bacterial culture results at time of survey were collected from medical records.
Results
Of 3,866 patients, 2327 were from tertiary, 1396 from secondary, and 141 from primary hospitals. Prevalence of antibacterial use in tertiary, secondary and primary hospitals was 56.7%, 52.7%, and 49.7%, respectively. The highest antibacterial use was in ICUs (92.9%), and lowest was in mixed medical-surgical wards (45.7%). Among tertiary and secondary hospitals, commonly prescribed antibacterials were amoxicillin-clavulanate (AMC) (20.4% of total number of antibacterials), 3rd generation cephalosporins (3GC) (19.5%), and metronidazole (10.8%). AMC (32.1%), 2nd generation cephalosporins (24.6%), and 1st generation cephalosporins (11.1%) were common in primary hospitals. Carbapenems use was 6.9% and 4.3% in tertiary and secondary hospitals respectively. AMC (30.3%) and 3GC (27.6%) were the most common in mixed medical-surgical (30.3%) and medical wards (27.6%) respectively while carbapenems were most common in ICUs (18.8%). Use of ‘Access’, ‘Watch’ and ‘Reserve’ group antibacterials was 58.3%, 40.4%, 1% in tertiary, 65.5%, 33.9%, 0.4% in secondary, and 91.3%, 8.6%, 0% in primary hospitals respectively.
Common indications for antibacterials across all healthcare levels were cellulitis/soft tissue infections (28.9%), lower respiratory tract infections (25.2%), and urinary tract infections (14.8%). Of all, 44.5% of patients on surgical prophylaxis and 20.6% on upper respiratory infections were prescribed inappropriate antibiotics. Associated microbiologic cultures were ordered in 37.5% of patients in tertiary, 18% in secondary hospitals.
Conclusions
This study describes the current landscape of antibacterial use in public hospitals in Sri Lanka. Adherence to antibiotic prescribing guidelines and the reduction of broad-spectrum antibacterial use were identified as two main antimicrobial stewardship targets.
Acknowledgements
Financial assistance by pilot grant fund from the Duke Global Health Institute is acknowledged.
This work has been previously presented at the American Society of Tropical Medicine and Hygiene (ASTMH) conference-2025 in Toronto, Canada.
